Cleared Traditional

ToxCO (K173238) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K173238 · Bedfont Scientific, Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
546d
Days
Class 2
Risk

K173238 is an FDA 510(k) clearance for the ToxCO. Classified as Analyzer, Gas, Carbon-monoxide, Gaseous-phase (product code CCJ), Class II - Special Controls.

Submitted by Bedfont Scientific, Ltd. (Maidstone, Kent, GB). The FDA issued a Cleared decision on April 4, 2019 after a review of 546 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1430 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Bedfont Scientific, Ltd. devices

Submission Details

510(k) Number K173238 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 05, 2017
Decision Date April 04, 2019
Days to Decision 546 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
406d slower than avg
Panel avg: 140d · This submission: 546d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase

All 7
Devices cleared under the same product code (CCJ) and FDA review panel - the closest regulatory comparables to K173238.
CoSense ETCO Monitor
K253119 · Capnia, Inc. · May 2026
iCOquit® Smokerlyzer®
K211918 · Bedfont Scientific, Ltd. · Dec 2021
Pivot Breath Sensor
K201206 · Carrot, Inc. · Jun 2021
CO Check Pro, CO Screen
K171129 · MD Diagnostics Limited · Mar 2018
ECOLYZER #200/COHB ANALYZER SYS
K832655 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1983
ARGYLE DOUBLE SEAL CHEST DRAINAGE UNIT
K802891 · Sherwood Medical Co. · Dec 1980